Table 1:
Inflammatory Environment | Cell type | Tissue | Signal or Mechanism | Example Markers | Functions and/or outcomes | Ref. |
---|---|---|---|---|---|---|
LPS in vivo | “Neutrophil-like” monocyte | BM, blood, spleen | LPS (unknown direct or indirect) | Ly6Chi, CCR2hi, CD115+, Elane, Prtn3, Ctsb, Serpinb1a, MPO | Primary granule proteases, microbicidal response | [9] [11] |
CpG DNA in vivo | “DC-like” monocyte | BM, blood, spleen | CpG DNA (unknown direct or indirect) | Ly6Chi, CCR2hi, CD115+, CD11c+ MHCIIhi, CD86hi, CD74, Flt3, CD209a | Antigen presentation genes | [9] [11] |
GM-CSF | CD209a+ moDC monocyte progenitor | BM, blood | High levels of PU.1 | CD115+,Ly6Chi, MHCII+, CD209a+, FcγRIII+, PU.1hi | DC-related genes and functions | [10] |
LPS, L.m. infection | iNOS+ macrophage monocyte progenitor | BM, blood | Low levels of PU.1 | CD115+, Ly6Chi, FcgRIII+, CD209a,MHCII-,PU.1lo | Microbicidal response | [10] |
Acute injury to bone marrow | HSCs → Myeloid differentiation | BM | Il-1β downstream of inflammasome activation | Mac-1, CD16/32, PU.1, GM-CSFR, M-CSFR, CD18 | Leads to Mac-1+Gr-1int pregranulocytes/ monocytes | [24] |
Caspase-1 inhibition of mouse HSCs in vitro; Overexpression of ASC & Caspa, S. Tminfection* | HSCs → GMP → MDPs → monocytes (and neutrophils) in mouse and zebrafish models; | Mouse BM; Zebrafish larvae | Caspase-1 cleavage of GATA-1 | N/A | Myelopoiesis over erythropoiesis | [25] |
L.m. infection | Tip-DCs | Spleen | Require NK cell-derived IFNγ | CD11bint, CD11cint, Mac-3hi, TNF, iNOS, MHCII | Bacterial clearance, host survival | [26] [27] [28] |
T. gondii infection | cMOP→ Ly6Chiregulatory monocytes | SI lamina propria | lipid mediator PGE2, Require IFNγ produced by NK cells | MHCII, Sca-1, CX3CR1++ | Controls neutrophilic inflammation in the gut | [38] [39] |
Bleomycin-induced lung fibrosis | GMP→SatMs | Lung | Unknown | CD115, myeloperoxidase and neutrophil elastase | Promote pathogenic fibrosis | [41] |
Chronic TLR7/TLR9 (SLE-MAS model), P. yoelii infection | Inflammatory hemophagocytes (iHPCs) | BM, spleen | Cell-intrinsic TLR7/9 & IRF5 (MAS), MyD88 & Unc93b1 (P. yoelii) | SpiC, CD11bhi, CD31hi, PDL2 | Hemophagocytosis, contribute to anemia & thrombocytopenia in SLE-MAS disease model | [42] |
Helicobacter hepaticusinduced colitis | Inflammatory macrophages | LI lamina propria | Require IRF5 | CD11c+, MHCII+ | Promote pathogenic intestinal inflammation | [35] |
Chikungunya virus infection | Inflammatory macrophages | Lymph node | Require IRF5 | CD11c+, MHCII+ | Disrupt lymph node structure & B cell response | [29] |
Atherosclerosis | Inflammatory macrophages | Aortic plaque | Require IRF5 | CD11c+, MHCII+ | Lesion development | [32] |
DSS-induced colitis | Regulatory monocytes | BM, spleen, blood | GM-CSF and IL-3 | Ly6ChiYm1+ | Promote tissue repair | [40] |
Nod2-driven inflammation | Patrolling monocytes | BM, Vasculature | Muramyl dipeptide, unknown direct vs indirect | CD115+Ly6CloCD43+LFA1+CX3CR1+ Nr4a1 | Crawling on endothelium | [48] |
Models of Lupus-like disease | Patrolling monocytes | Kidney vasculature | TLR7/9 & MyD88-dependent require Nod2 | CD115+,Ly6Clo, CD43hi, F4/80lo, Nr4a1, Cebpb, | Drive early glomerulonephritis | [49] [50] |
TLR7-driven inflammation | Patrolling monocytes | Vasculature | Dll1-Notch2 signaling | CD115+,Ly6Clo, CD43+, CD11c+, Nr4a1, Pou2f2 | Crawling on endothelium, Endothelial repair | [51] [52] |
Zebrafish